News

CARsgen® U.S. Clinical Holds Lifted by FDA

CARsgen Therapeutics

SHANGHAI,Nov. 1,2024-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors,

Home Previous 166 167 168 169 170 171 172 Next Tail

10 Items Per Page (Page 169 / 527) Total 5265 Items

©Copyright 2009-2020 Yahoo Perspective   cryydr@163.com   Contact Us   SiteMap